4 1 d53129_form4.txt FORM 4 ------------------------- OMB APPROVAL ------------------------- OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response....0.5 ------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |_| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). (Print or Type Responses) ________________________________________________________________________________ 1. Name and Address of Reporting Person* Kanzer Steve H. -------------------------------------------------------------------------------- (Last) (First) (Middle) 801 Brickell Avenue, Suite 942 -------------------------------------------------------------------------------- (Street) Miami FL 33131 -------------------------------------------------------------------------------- (City) (State) (Zip) ________________________________________________________________________________ 2. Issuer Name and Ticker or Trading Symbol DOR BioPharma, Inc (DOR) ________________________________________________________________________________ 3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary) ________________________________________________________________________________ 4. Statement for Month/Day/Year 12/31/02 ________________________________________________________________________________ 5. If Amendment, Date of Original (Month/Day/Year) ________________________________________________________________________________ 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) |X| Director |_| 10% Owner |X| Officer (give title below) |_| Other (specify below) Interim President ________________________________________________________________________________ 7. Individual or Joint/Group Filing (Check Applicable line) |X| Form Filed by One Reporting Person |_| Form Filed by More than One Reporting Person ________________________________________________________________________________ ================================================================================ Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned ================================================================================
5. Amount of 6. 4. Securities Owner- Securities Acquired (A) or Beneficially ship 2A. 3. Disposed of (D) Owned Form: 7. 2. Deemed Transaction (Instr. 3, 4 and 5) Following Direct Nature of Trans- Execution Code ------------------------------- Reported (D) or Indirect 1. action Date, if (Instr. 8) (A) Transaction(s) Indirect Beneficial Title of Security Date any ------------ or (Instr. 3 & (I) Ownership (Instr. 3) (mm/dd/yy) (mm/dd/yy) Code V Amount (D) Price Instr.4) (Instr.4) (Instr.4) ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 12/31/2002 A 285,714 A .350 285,714 I (1) $.001 Par Value ("Common Stock") private placement ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 403,095 D ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ====================================================================================================================================
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4(b)(v). Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. FORM 4 (continued) Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) ================================================================================
9. Number 10. of Owner- deriv- ship ative Form 2. Secur- of Conver- 5. 7. ities Deriv- 11. sion Number of Title and Amount Bene- ative Nature or Derivative 6. of Underlying 8. ficially Secur- of Exer- 3A. 4. Securities Date Securities Price Owned ity: In- cise Deemed Trans- Acquired (A) Exercisable and (Instr. 3 and 4) of Follow- Direct direct Price 3. Execut- action or Disposed Expiration Date ---------------- Deriv- ing (D) or Bene- 1. of Trans- ion Code of(D) (Month/Day/Year) Amount ative Reported In- ficial Title of Deriv- action Date if (Instr. (Instr. 3, ---------------- or Secur- Trans- direct Owner- Derivative ative Date any 8) 4 and 5) Date Expira- Number ity action(s) (I) ship Security Secur- (mm/dd/ (mm/dd/ ------ ------------ Exer- tion of (Instr. (Instr. (Instr. (Instr. (Instr. 3) ity yy) yy) Code V (A) (D) cisable Date Title Shares 5) 4) 4) 4) ------------------------------------------------------------------------------------------------------------------------------------ Stock .75 12/31/02 A 35,971 Immed. 12/31/07 Common 35,971 35,971 D Warrants Stock (right to buy) ------------------------------------------------------------------------------------------------------------------------------------ Stock .35 12/31/02 A 73,411 Immed. 12/31/07 Common 73,411 73,411 D Warrants Stock (right to buy) ------------------------------------------------------------------------------------------------------------------------------------ Stock .750 12/31/2002 A 142,857 Immed. 12/31/07 Common 142,857 142,857 I (1) Warrants Stock (right to buy) ------------------------------------------------------------------------------------------------------------------------------------ Stock .200 Immed. 10/23/12 Common 250,000 250,000 D Options Stock (right to buy) ------------------------------------------------------------------------------------------------------------------------------------ Stock .910 Immed. 12/05/11 Common 50,000 50,000 D Options Stock (right to buy) ------------------------------------------------------------------------------------------------------------------------------------ Stock .740 Immed. 11/29/11 Common 167,800 167,800 D Options Stock (right to Buy) ------------------------------------------------------------------------------------------------------------------------------------ Stock 1.250 Immed 2/21/11 Common 50,000 50,000 D Options Stock (right to Buy) ------------------------------------------------------------------------------------------------------------------------------------ Stock 1.375 Immed. 10/21/09 Common 12,000 12,000 D Options Stock (right to Buy) ------------------------------------------------------------------------------------------------------------------------------------ Stock 2.46875 Immed. 10/21/07 Common 42,000 42,000 D Options Stock (right to Buy) ------------------------------------------------------------------------------------------------------------------------------------ Stock 2.46875 Immed. 10/21/07 Common 145,000 145,000 D Options Stock (right to Buy) ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ====================================================================================================================================
Explanation of Responses: /s/ Steve Kanzer 1/2/2003 --------------------------------------------- ----------------------- **Signature of Reporting Person Date ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. (1) Mr. Kanzer acquired these securities through Accredited Venture Capital LLC, a limited liability corporation in which Mr. Kanzer is the sole member. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Page 2